Medtronic has appointed John Groetelaars and Bill Jellison to its board as independent directors, effective immediately, and formed two board committees.

Medtronic reported strong first-quarter 2026 results, with sales hitting $8.58 billion, surpassing the consensus estimate of ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the Medtronic Board of Directors has appointed John Groetelaars and Bill Jellison as independent directors, ...

Medtronic: The company did not raise the sales growth forecast for its fiscal 2026 despite strong quarterly results, sending ...

“Our decision to become one of Medtronic’s largest investors was driven by our strong conviction that the company is entering ...

Medtronic(NYSE:MDT) reported first quarter fiscal 2026 results on August 19, 2025, delivering 4.8% year-over-year organic revenue growth and adjusted earnings per share (EPS) of $1.26, which beat the ...

Medtronic officials today said that the company's planned separation of its Diabetes business is on the right track.

CEO Geoff Martha told investors that the initiatives were done in partnership with the activist investor firm Elliott ...

"Are we investing enough behind these big growth drivers? We think no. We want to invest more," Medtronic CEO Geoff Martha ...

Wall Street braced for results from retail giants as rising concerns over inflation cloud the path to an interest rate cut.

Medtronic has agreed to not only expand the size of its board of directors, but to also task it with taking a closer look at ...

Medtronic’s stock price has lagged behind competitors’ for years, with investors weary of the company’s pace of growth. But a ...